Parkinson’s Disease Research News

Newsfeed:

  • Blood pressure drug shows promise for treating Parkinson’s and dementia in animal study
    Felodipine, a common hypertension medication, induces autophagy and clears aggregate-prone proteins associated with neurodegenerative diseases. The study reveals the drug clears mutant alpha-synuclein in the brains of mice at plasma concentrations to those seen in humans taking the medication. Felodipine appears to have some neuroprotective properties in mouse models of neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-04-18By Neuroscience News
  • Blood pressure drug shows promise for treating Parkinson’s and dementia in animal study
    A prescribed drug to treat high blood pressure has shown promise against conditions such as Parkinson's, Huntington's and forms of dementia in studies carried out in mice and zebrafish. ... read more
    Source: Science DailyPublished on 2019-04-18
  • Blood pressure drug shows promise for treating Parkinson’s and dementia in animal study
    (University of Cambridge) A prescribed drug to treat high blood pressure has shown promise against conditions such as Parkinson's, Huntington's and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge. ... read more
    Source: Eureka AlertPublished on 2019-04-18
  • Technology automatically senses how Parkinson’s patients respond to medication
    (Florida Atlantic University) Adjusting the frequency and dosage of Parkinson's patients' medication is complex. In their 'ON' state they respond positively to medication and in their 'OFF' state symptoms return. Addressing these fluctuations requires a clinical exam, history-taking or a patient's self-report, which are not always practical or reliable. A new technology that combines an algorithm with a senor-based system ... read more
    Source: Eureka AlertPublished on 2019-04-17
  • Train your brain, change your brain
    (D'Or Institute for Research and Education) Less than one hour of brain training with neurofeedback leads to a strengthening of neural connections and communication among brain areas. This is the main finding of a new study conducted at D'Or Institute for Research and Education (IDOR), published today in Neuroimage. According to the authors, the study may pave the way for ... read more
    Source: Eureka AlertPublished on 2019-04-14
  • Experimental PET scan detects abnormal tau protein in brains of living former NFL players
    PET imaging of former NFL players who exhibited cognitive decline and psychiatric symptoms linked to CTE showed higher levels of tau in areas of the brain associated with the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-04-10By Neuroscience News
  • Time to resTOR in New Zealand
      As the amazing Australian Parkinson’s Mission project prepares to kick off, across the creek in my home land of New Zealand, another very interesting clinical trial programme for Parkinson’s is also getting started. The study is being conductetd by a US biotech firm called resTORbio Inc. The drug being tested in the study is called RTB101. It is ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-04-09By Simon
  • Virtual reality offers benefits for Parkinson’s disease patients
    Researchers are reporting early success with a new tool to help people with Parkinson's disease improve their balance and potentially decrease falls with high-tech help: virtual reality. After practicing with a virtual reality system for six weeks, people with Parkinson's disease demonstrated improved obstacle negotiation and balance along with more confidence navigating around obstacles in their path. ... read more
    Source: Science DailyPublished on 2019-04-09
  • How technology can help prompt positive memories for people with depression
    Researchers propose adapting computer technologies to help those with depression recall positive memories. Most existing technologies focused on supporting memory impairments are geared towards episodic memory recall and cognitive impairments related to neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-04-09By Neuroscience News
  • Advances in deep brain stimulation could lead to new treatments
    Researchers discuss the potential of deep brain stimulation in the treatment of Parkinson's disease, OCD, Tourette syndrome and other disorders. ... read more
    Source: Neuro Science NewsPublished on 2019-04-08By Neuroscience News
  • How education may stave off cognitive decline
    Neuroimaging reveals those who have spent more years studying have increased cortical thickness in the medial prefrontal cortex, anterior cingulate and orbitofrontal areas of the brain. Researchers also identified enhanced gene expression profiles in these brain regions that promote information processing and provide protection against some age-related neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-04-08By Neuroscience News
  • Advances in deep brain stimulation could lead to new treatments
    A new article suggests that recent advances in deep brain stimulation (DBS) for Parkinson disease could lead to treatments for conditions such as obsessive-compulsive disorder (OCD), Gilles de la Tourette syndrome and depression. The authors of the article argue that bi-directional electrodes which can both stimulate and record from deep brain structures -- known as closed-loop DBS -- could have ... read more
    Source: Science DailyPublished on 2019-04-08
  • Microglia, cells thought restricted to central nervous system, are redefined in new study
    In response to injury, microglia cross the spinal boundary from the central nervous system to the peripheral nervous system. While in the PNS, microglia provide the function of clearing cellular debris at the point of injury, then return to the CNS in an altered state. Researchers propose this could account for some damage associated with neurodegenerative diseases. ... read more
    Source: Neuro Science NewsPublished on 2019-04-07By Neuroscience News
  • When undruggable becomes druggable
      Nuclear receptor related 1 protein (or NURR1) is a protein that has been shown to have a powerful effect on the survival of dopamine neurons – a population of cells in the brain that is severely affected by Parkinson’s. For a long time researchers ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-04-05By Simon
  • Parkinson’s clues seen in tiny fish could aid quest for treatments
    Zebrafish study reveals how key dopaminergic neurons, which are damaged as a result of Parkinson's disease, can be regenerated. Researchers report the immune system plays a critical role in the process. ... read more
    Source: Neuro Science NewsPublished on 2019-04-05By Neuroscience News
  • Vitamin B12 identified as the inhibitor of a key enzyme in hereditary Parkinson’s disease
    Vitamin B12 significantly prevents the neurotoxicity of LRRK2 genetic variants associated with hereditary Parkinson's disease. The findings may help with the development of new therapies to combat the neurodegenerative disease. ... read more
    Source: Neuro Science NewsPublished on 2019-04-04By Neuroscience News
  • Parkinson’s clues seen in tiny fish could aid quest for treatments
    Parkinson's patients could be helped by fresh insights gained from studies of tiny tropical fish. Research using zebrafish has revealed how key brain cells that are damaged in people with Parkinson's disease can be regenerated. ... read more
    Source: Science DailyPublished on 2019-04-04
  • Vitamin B12 is identified as the inhibitor of a key enzyme in hereditary Parkinson’s disease
    Parkinson's is the most common, chronic neurodegenerative movement disorder affecting 1% of the global population over seventy years of age. Right now, there is no cure for this disease and the available treatments focus on addressing its symptoms but not its progression. ... read more
    Source: Science DailyPublished on 2019-04-04
  • The 2019 ADPD meeting
      On the 26-31st March, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases (or ADPD meeting) was held in Lisbon, Portugal. For 5 days – between 8:30am and 7:30pm each day – over 4000 researchers were able to attend lectures of new results and ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-04-02By Simon
  • A “Low Dose Aspirin” for Dementia? Drug Ready for First in-Human Testing
    MW-151, a new drug that blocks 'bad' inflammation in the brain is about to be tested in a new human trial. Researchers believe the new drug could help stave off dementia. ... read more
    Source: Neuro Science NewsPublished on 2019-04-02By Neuroscience News
  • A shorter reproductive window in women linked to increased dementia risk
    Reproductive spans of less than 34 years were linked to an increased risk of developing dementia in women. In those who had hysterectomies, the associated Alzheimer's risk was elevated by 8%. ... read more
    Source: Neuro Science NewsPublished on 2019-04-02By Neuroscience News
  • Alzheimer’s diagnosis and management improved by brain scans
    PET imaging that helps detect dementia-related amyloid plaques significantly influences the clinical management of patients, a new study reports. ... read more
    Source: Neuro Science NewsPublished on 2019-04-02By Neuroscience News
  • Circadian clock plays unexpected role in neurodegenerative diseases
    Disrupted sleep patterns may help to protect neurons in the brain in Huntington's disease. ... read more
    Source: Neuro Science NewsPublished on 2019-04-02By Neuroscience News
  • Monthly Research Review – March 2019
      At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during March 2019. The post is divided into seven parts based on the type of research: ... read more
    Source: The Science of Parkinson’s diseasePublished on 2019-03-31By Simon
  • Virtual reality could be used to treat autism, schizophrenia and Parkinson’s
    Virtual reality can help recalibrate time perception and sensorimotor actions. Researchers believe the technology could help in the treatment of ASD, Parkinson's disease and schizophrenia. ... read more
    Source: Neuro Science NewsPublished on 2019-03-31By Neuroscience News
1 2 3 57